Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunhapas Soodvilai

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
American Journal of Physiology. Renal Physiology|August 30, 2008
Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injuryHaiying Liu, Zhanjun Jia, Zhunjun Jia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 31, 2026
Corrigendum to "ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling" [Biomed. Pharmacother. 193 (2025) 118884]Nareerat Sutjarit, Klodthida Yanukun, Kanit Bhukhai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2026
Erratum to "ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling" [Biomed. Pharmacother. 193 (2025) 118884]Nareerat Sutjarit, Klodthida Yanukun, Kanit Bhukhai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 9, 2025
ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signalingNareerat Sutjarit, Klodthida Yanukun, Kanit Bhukhai, et al.
Cell Metabolism|December 2, 2008
Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1Ningning Wang, Guangrui Yang, Zhanjun Jia, et al.
Cancers|January 8, 2025
Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for CholangiocarcinomaSimran Venkatraman, Brinda Balasubramanian, Pornparn Kongpracha, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
American Journal of Physiology. Renal Physiology|August 30, 2008
Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injuryHaiying Liu, Zhanjun Jia, Zhunjun Jia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 31, 2026
Corrigendum to "ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling" [Biomed. Pharmacother. 193 (2025) 118884]Nareerat Sutjarit, Klodthida Yanukun, Kanit Bhukhai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2026
Erratum to "ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signaling" [Biomed. Pharmacother. 193 (2025) 118884]Nareerat Sutjarit, Klodthida Yanukun, Kanit Bhukhai, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 9, 2025
ASPP-092, a Curcuma comosa diarylheptanoid, inhibits the adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via activation of TGF-β/SMAD2/3 signalingNareerat Sutjarit, Klodthida Yanukun, Kanit Bhukhai, et al.
Cell Metabolism|December 2, 2008
Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1Ningning Wang, Guangrui Yang, Zhanjun Jia, et al.
Cancers|January 8, 2025
Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for CholangiocarcinomaSimran Venkatraman, Brinda Balasubramanian, Pornparn Kongpracha, et al.
Pageof 7